Immunic, Inc.
IMUX· Nasdaq
Released Feb 26, 2026, before the open
10-K filed Feb 26, 2026, 57 days after period end · 0001280776-26-000005
derived · Computed from the longer spans the company filed.
| Metric | Q4 2025dderived from reported figures | Q4 2024dderived from reported figures | Q4 2023dderived from reported figures | Q4 2022dderived from reported figures |
|---|---|---|---|---|
| Net Income | -$19.30M | -$25.18M | -$21.57M | -$56.47M |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Immunic, Inc. · CIK 1280776 · Engraved from SEC EDGAR
Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.
ended Dec 31, 2025 · filed Feb 26, 2026 · 57 d after period end
+4.3% from the close of Feb 25, 2026 to the close of Feb 26, 2026, the first after the release.